Recombinant murine gamma interferon inhibits Chlamydia trachomatis serovar L1 in vivo.
AUTOR(ES)
Zhong, G M
RESUMO
Chlamydia trachomatis serovar L1 injected intravenously in mice resulted in systemic nonlethal infections of the animals. Treatment of mice with recombinant murine gamma interferon resulted in a decrease in the number of infectious C. trachomatis organisms recovered from the lungs, spleens, and livers as well as in a decrease of the inflammatory reaction in those organs when assessed 3 and 5 days after challenge.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=259272Documentos Relacionados
- Activation of mouse peritoneal macrophages in vitro or in vivo by recombinant murine gamma interferon inhibits the growth of Chlamydia trachomatis serovar L1.
- Gamma interferon-mediated cytotoxicity related to murine Chlamydia trachomatis infection.
- Differences in the association of Chlamydia trachomatis serovar E and serovar L2 with epithelial cells in vitro may reflect biological differences in vivo.
- Characterization of native and recombinant 75-kilodalton immunogens from Chlamydia trachomatis serovar L2.
- Role in vivo for gamma interferon in control of pneumonia caused by Chlamydia trachomatis in mice.
